当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析

共同药业

(300966)

  

流通市值:19.17亿  总市值:28.83亿
流通股本:7666.67万   总股本:1.15亿

共同药业(300966)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.01亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益91060.87万元,未分配利润22065.41万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产289612.17万元,负债198551.30万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入161,937,521.77606,178,267.31455,071,340.26302,399,640.34
营业总成本163,784,967.65708,683,380.01505,144,105.05327,673,538.83
其他经营收益
营业利润-1,287,926.03-100,985,005.67-52,441,061.48-21,819,689.85
利润总额-1,277,717.82-105,214,803.97-53,658,033.91-23,157,693.17
净利润1,122,583.06-81,726,282.34-37,430,322.36-14,654,445.7
每股收益
其他综合收益0---
综合收益总额1,122,583.06-81,726,282.34-37,430,322.36-14,654,445.7
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计825,170,510.54770,287,408.19779,686,448.17854,580,712.74
非流动资产:
非流动资产合计2,070,951,176.332,080,370,851.022,077,076,297.232,080,593,817.29
资产总计2,896,121,686.872,850,658,259.212,856,762,745.42,935,174,530.03
流动负债:
流动负债合计833,211,748822,076,779.57762,840,757.28821,744,569.28
非流动负债:
非流动负债合计1,152,301,282.891,119,224,533.761,136,016,467.931,116,108,568.7
负债合计1,985,513,030.891,941,301,313.331,898,857,225.211,937,853,137.98
所有者权益(或股东权益):
归属于母公司股东权益合计829,547,390.29826,219,731.57871,396,588.82909,318,935.08
股东权益合计910,608,655.98909,356,945.88957,905,520.19997,321,392.05
负债和股东权益合计2,896,121,686.872,850,658,259.212,856,762,745.42,935,174,530.03
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计100,396,109.21587,686,880.95412,169,849.05222,850,365.81
经营活动现金流出小计100,294,235.11546,650,490.62418,335,857.41228,643,260.64
经营活动产生的现金流量净额101,874.141,036,390.33-6,166,008.36-5,792,894.83
投资活动产生的现金流量:
投资活动现金流入小计2,832183,709133,709133,709
投资活动现金流出小计26,054,569.82166,326,364.17141,243,927.94115,639,950.77
投资活动产生的现金流量净额-26,051,737.82-166,142,655.17-141,110,218.94-115,506,241.77
筹资活动产生的现金流量:
筹资活动现金流入小计110,000,000468,380,787.85413,800,628.84280,029,384.62
筹资活动现金流出小计98,292,027.56378,195,138.34285,227,544.88160,996,327.64
筹资活动产生的现金流量净额11,707,972.4490,185,649.51128,573,083.96119,033,056.98
汇率变动对现金及现金等价物的影响2.94-64,040.56-43,987.3689,458.9
现金及现金等价物净增加额-14,241,888.34-34,984,655.89-18,747,130.7-2,176,620.72
期末现金及现金等价物余额50,895,488.7965,137,377.1381,374,902.3297,945,412.3
补充资料:
现金及现金等价物的净增加额--34,984,655.89--2,176,620.72
TOP↑